跳到正文
原文
Journal of Clinical Oncology 临床肿瘤· Jian Zhang·· 2026-10-02AI 评分46

Trastuzumab Botidotin 对比 Trastuzumab Emtansine 治疗 HER2 阳性晚期乳腺癌:III 期开放随机对照试验

Trastuzumab Botidotin Versus Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: A Phase III, Open-Label, Randomized Controlled Trial

AI 导读

该 III 期开放随机对照试验对比 Trastuzumab Botidotin 与 Trastuzumab Emtansine 在 HER2 阳性晚期乳腺癌中的疗效,原文为 Journal of Clinical Oncology 预上线摘要,未提供完整数据。

来源:Journal of Clinical Oncology 临床肿瘤 · ascopubs.org